CSE: 2017-0204 - Suspension - Abattis Bioceuticals Corp. (ATT)
TORONTO, ONTARIO--(Marketwired - Feb 6, 2017) - Abattis Bioceuticals Corp. is in default of CSE requirements. Effective immediately, Abattis Bioceuticals will be suspended pursuant to CSE Policy 3. The suspension is considered a Regulatory Halt as defined …